Luye Pharma Group is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications. The company has established R&D centers in China, the U.S. and the EU, with a robust pipeline of more than 40 drug candidates in China and more than 10 drug candidates overseas. Luye Pharma has set up 7 manufacturing sites with over 30 production lines in total, establishing GMP quality management and international standard control systems. The company offers more than 30 products covering the 4 largest and fastest growing therapeutic areas — oncology, cardiovascular, metabolism and central nervous system, with business conducted in over 80 countries and regions across the world.

Headquartered in Singapore, Luye Medical is the regional healthcare services arm of Luye Life Sciences Group. Through strategic acquisitions and partnerships with leading healthcare organizations, we adopt and develop world-leading technology as well as operational and management systems.
We are committed to provide quality integrated healthcare services to patients both locally and globally, and our vision is to become a leader in the global healthcare industry.

Through real-time fluorescent qPCR and next-generation sequencing (NGS) technologies in combination with data platforms, Luye Diagnostics provides clinical, intelligent, complete solutions in different stages of the disease.

Patronus Biotech, a subsidiary of Luye Life Sciences Group, focuses on the development, manufacturing and commercialization of new technology route vaccines and strives to be a pioneer in the industry.